At the time of writing, Merit Medical Systems, Inc. [MMSI] stock is trading at $76.63, up 3.41%. An important factor to consider is whether the stock is rising or falling in short-term value. The MMSI shares have gain 3.51% over the last week, with a monthly amount glided 6.00%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Merit Medical Systems, Inc. [NASDAQ: MMSI] stock has seen the most recent analyst activity on April 11, 2024, when CL King initiated its Buy rating and assigned the stock a price target of $88. Previously, BofA Securities started tracking the stock with Neutral rating on February 07, 2024, and set its price target to $87. On December 21, 2023, upgrade upgraded it’s rating to Buy but maintained its price target of $100 on the stock. Canaccord Genuity downgraded its rating to a Hold and decreased its price target to $72 on December 20, 2022. Needham upgraded its rating to a Buy but $65 remained the price target by the analyst firm on January 05, 2021. Wells Fargo upgraded its rating to Equal Weight for this stock on September 28, 2020, but kept the price target unchanged to $42. In a note dated February 25, 2020, Barrington Research downgraded an Mkt Perform rating on this stock.
For the past year, the stock price of Merit Medical Systems, Inc. fluctuated between $62.58 and $85.62. Currently, Wall Street analysts expect the stock to reach $83.5 within the next 12 months. Merit Medical Systems, Inc. [NASDAQ: MMSI] shares were valued at $76.63 at the most recent close of the market. An investor can expect a potential return of 8.97% based on the average MMSI price forecast.
Analyzing the MMSI fundamentals
According to Merit Medical Systems, Inc. [NASDAQ:MMSI], the company’s sales were 1.25B for trailing twelve months, which represents an 11.04% jump. Gross Profit Margin for this corporation currently stands at 0.45% with Operating Profit Margin at 0.1%, Pretax Profit Margin comes in at 0.09%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 18.47, Equity is 0.08 and Total Capital is -0.75. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 74.28 points at the first support level, and at 71.92 for the second support level. However, for the 1st resistance point, the stock is sitting at 78.78, and for the 2nd resistance point, it is at 80.92.
Merit Medical Systems, Inc. [MMSI] reported earnings per share of $0.77 for its fiscal quarter that ended on 3/31/2024. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.71/share, meaning a difference of $0.06 and a surprise factor of 8.50%. By comparison, the stated earnings for the previous quarter ended on 12/31/2023 were $0.81 per share as compared to estimates of $0.76 per share, a difference of $0.05 representing a surprise of 6.60%.
Ratios To Look Out For
It is important to note that Merit Medical Systems, Inc. [NASDAQ:MMSI] has a current ratio of 5.45. On the other hand, the Quick Ratio is 3.95. Considering the valuation of this stock, the price to sales ratio is 3.54, the price to book ratio is 3.69 and price to earnings (TTM) ratio is 47.37.
Transactions by insiders
Recent insider trading involved Parra Raul Jr., CFO AND TREASURER, that happened on Mar 12 ’24 when 6480.0 shares were sold. CHIEF COMMERCIAL OFFICER, Wright Joseph completed a deal on Mar 07 ’24 to sell 25000.0 shares. Meanwhile, Director Gunderson Thomas James sold 18157.0 shares on Mar 04 ’24.
